Ran Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
- Urology top 5%
- Molecular Biology top 5%
- Rehabilitation top 5%
- Oncology top 10%
-
- Bladder and Urothelial Cancer Treatments 17
- Urinary and Genital Oncology Studies 9
-
- Congenital Heart Disease Studies 10
-
- Kidney Stones and Urolithiasis Treatments 7
-
- Cardiovascular Issues in Pregnancy 7
- Cardiovascular Function and Risk Factors 7
- Journals
- Frontiers in Cardiovascular Medicine (6 papers)Scientific Reports (5 papers)PLoS ONE (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ran Xu
165 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 641
- Urology 142
- Molecular Biology 1.3k
- Rehabilitation 96
- Oncology 366
Countries citing papers authored by Ran Xu
This map shows the geographic impact of Ran Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xu more than expected).
Fields of papers citing papers by Ran Xu
This network shows the impact of papers produced by Ran Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xu. The network helps show where Ran Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 10 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 8 | |
| 18 | The Long Non-Coding RNA-RoR Promotes the Tumorigenesis of Human Colorectal Cancer by Targeting miR-6833-3p Through SMC4 | 2020 | 2 |
| 19 | Transient wave response analysis of a bridge under vertical earthquakes | 2012 | 1 |
| 20 | Treatment of extensive injuries in the middle and lower ureter with Boari flap(A report of 17 cases) | 2010 | 1 |
About Ran Xu
Ran Xu is a scholar working on Cancer Research, Obstetrics and Gynecology, Urology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 188 papers that have together received 3.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (17 papers), Congenital Heart Disease Studies (10 papers), Urinary and Genital Oncology Studies (9 papers), MicroRNA in disease regulation (8 papers), Kidney Stones and Urolithiasis Treatments (7 papers), Cardiovascular Issues in Pregnancy (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (641 citations), Urology (142 citations), Molecular Biology (1.3k citations), Rehabilitation (96 citations) and Oncology (366 citations). Ran Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaokun Zhao, Zhaohui Zhong, Xuan Zhu, Hui Xie, Zhen‐Xing Wang, Chun‐Yuan Chen, Shan‐Shan Rao, Jia Cao, Jing Zhu and Xu Chen. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Scientific Reports, PLoS ONE, Oncotarget and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.